Skip to main content
30 Apr 2020
UCB's General Meeting of Shareholders
Read More
23 Apr 2020
Acquisitions of own shares and Disposals of own shares
Read More
10 Apr 2020
Acquisitions of own shares and Disposals of own shares
Read More
10 Apr 2020
UCB's General Meeting of Shareholders
Read More
3 Apr 2020
Acquisitions of own shares and Disposals of own shares
Read More
2 Apr 2020
UCB completes the acquisition of Ra Pharmaceuticals – to deliver differentiated therapies to patients
Read More
24 Mar 2020
Share Repurchase Program to cover UCB's Long Term Incentive Plans for its employees
Read More
24 Mar 2020
18 Mar 2020
13 Mar 2020
UCB provides an update on Phase 2b padsevonil safety and efficacy study in epilepsy (ARISE)
Read More
Subscribe to
